Product Code: GMDHC07415CDB
Summary
Global Markets Direct's, 'NuCana BioMed Limited - Product Pipeline Review - 2015', provides an overview of the NuCana BioMed Limited's pharmaceutical research and development focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of NuCana BioMed Limited's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides brief overview of NuCana BioMed Limited including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of NuCana BioMed Limited's human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the NuCana BioMed Limited's pipeline products
Reasons to buy
- Evaluate NuCana BioMed Limited's strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of NuCana BioMed Limited in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the NuCana BioMed Limited's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of NuCana BioMed Limited and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of NuCana BioMed Limited
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of NuCana BioMed Limited and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
Table of Contents
- Table of Contents
- List of Tables
- List of Figures
- NuCana BioMed Limited Snapshot
- NuCana BioMed Limited Overview
- Key Information
- Key Facts
- NuCana BioMed Limited - Research and Development Overview
- NuCana BioMed Limited - Pipeline Review
- Pipeline Products by Stage of Development
- Pipeline Products - Monotherapy
- NuCana BioMed Limited - Pipeline Products Glance
- NuCana BioMed Limited - Clinical Stage Pipeline Products
- Phase II Products/Combination Treatment Modalities
- Phase I Products/Combination Treatment Modalities
- NuCana BioMed Limited - Early Stage Pipeline Products
- IND/CTA Filed Products/Combination Treatment Modalities
- Preclinical Products/Combination Treatment Modalities
- NuCana BioMed Limited - Drug Profiles
- NUC-1031
- Product Description
- Mechanism of Action
- R&D Progress
- NUC-3373
- Product Description
- Mechanism of Action
- R&D Progress
- NUC-7738
- Product Description
- Mechanism of Action
- R&D Progress
- NUC-4545
- Product Description
- Mechanism of Action
- R&D Progress
- NUC-5435
- Product Description
- Mechanism of Action
- R&D Progress
- NUC-6285
- Product Description
- Mechanism of Action
- R&D Progress
- NUC-9000
- Product Description
- Mechanism of Action
- R&D Progress
- NUC-9324
- Product Description
- Mechanism of Action
- R&D Progress
- NuCana BioMed Limited - Pipeline Analysis
- NuCana BioMed Limited - Pipeline Products by Target
- NuCana BioMed Limited - Pipeline Products by Route of Administration
- NuCana BioMed Limited - Pipeline Products by Molecule Type
- NuCana BioMed Limited - Pipeline Products by Mechanism of Action
- NuCana BioMed Limited - Recent Pipeline Updates
- NuCana BioMed Limited - Dormant Projects
- NuCana BioMed Limited - Locations And Subsidiaries
- Appendix
- Methodology
- Coverage
- Secondary Research
- Primary Research
- Expert Panel Validation
- Contact Us
- Disclaimer
List of Tables
- NuCana BioMed Limited, Key Information
- NuCana BioMed Limited, Key Facts
- NuCana BioMed Limited - Pipeline by Indication, 2015
- NuCana BioMed Limited - Pipeline by Stage of Development, 2015
- NuCana BioMed Limited - Monotherapy Products in Pipeline, 2015
- NuCana BioMed Limited - Phase II, 2015
- NuCana BioMed Limited - Phase I, 2015
- NuCana BioMed Limited - IND/CTA Filed, 2015
- NuCana BioMed Limited - Preclinical, 2015
- NuCana BioMed Limited - Pipeline by Target, 2015
- NuCana BioMed Limited - Pipeline by Route of Administration, 2015
- NuCana BioMed Limited - Pipeline by Molecule Type, 2015
- NuCana BioMed Limited - Pipeline Products by Mechanism of Action, 2015
- NuCana BioMed Limited - Recent Pipeline Updates, 2015
- NuCana BioMed Limited - Dormant Developmental Projects,2015
List of Figures
- NuCana BioMed Limited - Pipeline by Top 10 Indication, 2015
- NuCana BioMed Limited - Pipeline by Stage of Development, 2015
- NuCana BioMed Limited - Monotherapy Products in Pipeline, 2015
- NuCana BioMed Limited - Pipeline by Top 10 Target, 2015
- NuCana BioMed Limited - Pipeline by Top 10 Route of Administration, 2015
- NuCana BioMed Limited - Pipeline by Top 10 Molecule Type, 2015
- NuCana BioMed Limited - Pipeline Products by Top 10 Mechanism of Action, 2015
